Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study-Reference-Cited by-同舟云学术

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

Published:2020-10 Issue:10 Volume:7 Page:e688-e698
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Baden Lindsey R,Stieh Daniel J,Sarnecki Michal,Walsh Stephen R,Tomaras Georgia D,Kublin James G,McElrath M Juliana,Alter Galit,Ferrari Guido,Montefiori David,Mann Philipp,Nijs Steven,Callewaert Katleen,Goepfert Paul,Edupuganti Srilatha,Karita Etienne,Langedijk Johannes P,Wegmann Frank,Corey Lawrence,Pau Maria G,Barouch Dan H,Schuitemaker Hanneke,Tomaka Frank,Ake Julie A.,Buchbinder Susan,Buleza Karen,Cohen Kristen W.,Crowell Trevor A.,Euler Zelda,Frank Ian,Goedhart Dimitri,Keefer Michael,Kelly Colleen,Mayer Ken,Nkolola Joseph,Peter Lauren,Robb Merlin L.,Rouphael Nadine,Scheppler Lorenz,Sobieszczyk Magda,Van Tieu Hong

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference22 articles.

1. An HIV vaccine is essential for ending the HIV/AIDS pandemic;Fauci;JAMA,2017

2. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine;Hammer;N Engl J Med,2013

3. Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study;Gray;Lancet Infect Dis,2011

4. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection;Flynn;J Infect Dis,2005

5. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;Buchbinder;Lancet,2008

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study;eBioMedicine;2024-10

2. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

3. Human Immunodeficiency Virus Vaccine;Infectious Disease Clinics of North America;2024-09

4. Clinical trials and recent progress in HIV vaccine development;Functional & Integrative Genomics;2024-08-28

5. Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa;Vaccines;2024-07-03